Do analysts recommend AVNS or SNAL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Snail 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is AVNS or SNAL more profitable?

Snail has a net margin of -8.83% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat Snail's return on equity. Company Net Margins Return on Equity Return on Assets Avanos Medical -10.39% 5.39% 3.97% Snail -8.83% -15.49% -13.52%

Do analysts rate ICUI or AVNS?

ICU Medical currently has a consensus price target of $192.80, indicating a potential upside of 22.66%. Given ICU Medical's stronger consensus rating and higher possible upside, analysts plainly believe ICU Medical is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ICU Medical 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.89 Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has preferable earnings & valuation, ICUI or AVNS?

ICU Medical has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ICU Medical $2.23B 1.76 $730K $1.18 133.20 Avanos Medical $715.90M 1.64 -$72.90M -$1.61 N/A

Do analysts recommend NVST or AVNS?

Envista presently has a consensus target price of $29.79, indicating a potential upside of 31.16%. Given Envista's stronger consensus rating and higher possible upside, analysts plainly believe Envista is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envista 0 Sell rating(s) 10 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.41 Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has stronger earnings and valuation, NVST or AVNS?

Envista has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Envista $2.72B 1.34 $47M $0.58 39.15 Avanos Medical $715.90M 1.64 -$72.90M -$1.61 N/A

Do analysts prefer NEOG or AVNS?

Neogen currently has a consensus target price of $12.67, suggesting a potential upside of 8.17%. Given Neogen's stronger consensus rating and higher possible upside, research analysts clearly believe Neogen is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neogen 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has stronger earnings & valuation, NEOG or AVNS?

Neogen has higher revenue and earnings than Avanos Medical. Neogen is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Neogen $870.40M 2.93 -$7.90M -$0.03 N/A Avanos Medical $715.90M 1.64 -$72.90M -$1.61 N/A

Is NEOG or AVNS more profitable?

Neogen has a net margin of -6.35% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat Neogen's return on equity. Company Net Margins Return on Equity Return on Assets Neogen -6.35% 3.29% 2.06% Avanos Medical -10.39% 5.39% 3.97%

Do analysts prefer AVNS or UFPT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Avanos Medical (AVNS) Competitors

$24.99 0.00 (0.00%)

As of 10/8/2026

Compare

AVNS vs. SNAL, ICUI, NVST, NEOG, and UFPT

Should you buy Avanos Medical stock or one of its competitors? Avanos Medical's main competitors and comparable companies include Snail (SNAL), ICU Medical (ICUI), Envista (NVST), Neogen (NEOG), and UFP Technologies (UFPT). Companies are selected based on similarities in market, industry, and size.

How does Avanos Medical compare to Snail?

Avanos Medical (NYSE:AVNS) and Snail (NASDAQ:SNAL) are related small-cap companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.

Snail has a net margin of -8.83% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat Snail's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
Snail	-8.83%	-15.49%	-13.52%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Snail	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Snail had 4 more articles in the media than Avanos Medical. MarketBeat recorded 4 mentions for Snail and 0 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 0.00 beat Snail's score of -0.01 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Avanos Medical	Neutral
Snail	Neutral

Snail has lower revenue, but higher earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Snail, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A
Snail	$81.23M	0.25	-$27.24M	-$1.26	N/A

95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 0.4% of Snail shares are owned by institutional investors. 2.3% of Avanos Medical shares are owned by company insiders. Comparatively, 66.8% of Snail shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Avanos Medical has a beta of 1.57, meaning that its stock price is 57% more volatile than the broader market. Comparatively, Snail has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market.

Summary

Snail beats Avanos Medical on 8 of the 15 factors compared between the two stocks.

How does Avanos Medical compare to ICU Medical?

ICU Medical (NASDAQ:ICUI) and Avanos Medical (NYSE:AVNS) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.

ICU Medical has a net margin of 1.39% compared to Avanos Medical's net margin of -10.39%. ICU Medical's return on equity of 7.91% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ICU Medical	1.39%	7.91%	4.17%
Avanos Medical	-10.39%	5.39%	3.97%

ICU Medical currently has a consensus price target of $192.80, indicating a potential upside of 22.66%. Given ICU Medical's stronger consensus rating and higher possible upside, analysts plainly believe ICU Medical is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICU Medical	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.89
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

ICU Medical has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.57, suggesting that its share price is 57% more volatile than the broader market.

In the previous week, ICU Medical had 2 more articles in the media than Avanos Medical. MarketBeat recorded 2 mentions for ICU Medical and 0 mentions for Avanos Medical. ICU Medical's average media sentiment score of 0.51 beat Avanos Medical's score of 0.00 indicating that ICU Medical is being referred to more favorably in the media.

Company	Overall Sentiment
ICU Medical	Positive
Avanos Medical	Neutral

96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 95.2% of Avanos Medical shares are owned by institutional investors. 2.1% of ICU Medical shares are owned by company insiders. Comparatively, 2.3% of Avanos Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

ICU Medical has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICU Medical	$2.23B	1.76	$730K	$1.18	133.20
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A

Summary

ICU Medical beats Avanos Medical on 15 of the 17 factors compared between the two stocks.

How does Avanos Medical compare to Envista?

Envista (NYSE:NVST) and Avanos Medical (NYSE:AVNS) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

Envista has a net margin of 3.33% compared to Avanos Medical's net margin of -10.39%. Envista's return on equity of 7.88% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	3.33%	7.88%	4.33%
Avanos Medical	-10.39%	5.39%	3.97%

Envista presently has a consensus target price of $29.79, indicating a potential upside of 31.16%. Given Envista's stronger consensus rating and higher possible upside, analysts plainly believe Envista is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	10 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.41
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

95.2% of Avanos Medical shares are held by institutional investors. 1.0% of Envista shares are held by insiders. Comparatively, 2.3% of Avanos Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Envista had 5 more articles in the media than Avanos Medical. MarketBeat recorded 5 mentions for Envista and 0 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 0.00 beat Envista's score of -0.09 indicating that Avanos Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Envista	Neutral
Avanos Medical	Neutral

Envista has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.34	$47M	$0.58	39.15
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A

Envista has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.57, meaning that its stock price is 57% more volatile than the broader market.

Summary

Envista beats Avanos Medical on 11 of the 16 factors compared between the two stocks.

How does Avanos Medical compare to Neogen?

Neogen (NASDAQ:NEOG) and Avanos Medical (NYSE:AVNS) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

Neogen has higher revenue and earnings than Avanos Medical. Neogen is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neogen	$870.40M	2.93	-$7.90M	-$0.03	N/A
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A

Neogen has a beta of 1.79, indicating that its stock price is 79% more volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market.

Neogen currently has a consensus target price of $12.67, suggesting a potential upside of 8.17%. Given Neogen's stronger consensus rating and higher possible upside, research analysts clearly believe Neogen is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neogen	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Neogen has a net margin of -6.35% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neogen	-6.35%	3.29%	2.06%
Avanos Medical	-10.39%	5.39%	3.97%

In the previous week, Neogen had 45 more articles in the media than Avanos Medical. MarketBeat recorded 45 mentions for Neogen and 0 mentions for Avanos Medical. Neogen's average media sentiment score of 0.53 beat Avanos Medical's score of 0.00 indicating that Neogen is being referred to more favorably in the media.

Company	Overall Sentiment
Neogen	Positive
Avanos Medical	Neutral

96.7% of Neogen shares are owned by institutional investors. Comparatively, 95.2% of Avanos Medical shares are owned by institutional investors. 0.5% of Neogen shares are owned by insiders. Comparatively, 2.3% of Avanos Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Neogen beats Avanos Medical on 12 of the 16 factors compared between the two stocks.

How does Avanos Medical compare to UFP Technologies?

Avanos Medical (NYSE:AVNS) and UFP Technologies (NASDAQ:UFPT) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 87.3% of UFP Technologies shares are owned by institutional investors. 2.3% of Avanos Medical shares are owned by company insiders. Comparatively, 4.6% of UFP Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Avanos Medical has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.04, indicating that its stock price is 4% more volatile than the broader market.

UFP Technologies has a net margin of 11.45% compared to Avanos Medical's net margin of -10.39%. UFP Technologies' return on equity of 18.42% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
UFP Technologies	11.45%	18.42%	11.96%

In the previous week, UFP Technologies had 3 more articles in the media than Avanos Medical. MarketBeat recorded 3 mentions for UFP Technologies and 0 mentions for Avanos Medical. UFP Technologies' average media sentiment score of 0.45 beat Avanos Medical's score of 0.00 indicating that UFP Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Avanos Medical	Neutral
UFP Technologies	Neutral

UFP Technologies has lower revenue, but higher earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A
UFP Technologies	$602.80M	3.68	$68.31M	$9.28	30.88

Summary

UFP Technologies beats Avanos Medical on 11 of the 14 factors compared between the two stocks.

Get Avanos Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVNS vs. The Competition

Export

Metric	Avanos Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$1.17B	$5.44B	$7.20B	$22.99B
Dividend Yield	N/A	1.78%	2.53%	3.72%
P/E Ratio	-15.52	25.46	274.54	28.65
Price / Sales	1.64	70.40	585.60	23.57
Price / Cash	7.30	32.10	76.82	36.46
Price / Book	1.49	5.93	11.21	4.72
Net Income	-$72.90M	$146.18M	$3.50B	$1.07B
7 Day Performance	N/A	-0.40%	-0.68%	0.47%
1 Month Performance	N/A	-3.34%	-5.29%	-3.68%
1 Year Performance	121.44%	2.75%	4.62%	6.66%

Avanos Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVNS Avanos Medical	0.0568 of 5 stars	$24.99 flat	N/A	N/A	$1.17B	$715.90M	N/A	4,040	Positive News
SNAL Snail	1.7371 of 5 stars	$2.36 -2.3%	N/A	-59.6%	$21.18M	$81.23M	N/A	166
ICUI ICU Medical	3.6157 of 5 stars	$162.31 -1.1%	$192.80 +18.8%	+30.6%	$4.06B	$2.23B	137.66	13,000	Positive News
NVST Envista	3.84 of 5 stars	$23.32 -1.7%	$29.79 +27.7%	+10.3%	$3.74B	$2.72B	40.15	12,000	Analyst Forecast
NEOG Neogen	2.3461 of 5 stars	$13.24 -3.5%	$12.00 -9.3%	+101.2%	$2.91B	$870.40M	N/A	1,257	Trending News Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AVNS) was last updated on 10/9/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avanos Medical (AVNS) Competitors

AVNS vs. SNAL, ICUI, NVST, NEOG, and UFPT

How does Avanos Medical compare to Snail?

Summary

How does Avanos Medical compare to ICU Medical?

Summary

How does Avanos Medical compare to Envista?

Summary

How does Avanos Medical compare to Neogen?

Summary

How does Avanos Medical compare to UFP Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS vs. The Competition

Avanos Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Avanos Medical (AVNS) Competitors

AVNS vs. SNAL, ICUI, NVST, NEOG, and UFPT

How does Avanos Medical compare to Snail?

Is AVNS or SNAL more profitable?

Do analysts recommend AVNS or SNAL?

Does the media prefer AVNS or SNAL?

Which has preferable earnings and valuation, AVNS or SNAL?

Do institutionals & insiders have more ownership in AVNS or SNAL?

Which has more volatility & risk, AVNS or SNAL?

Summary

How does Avanos Medical compare to ICU Medical?

Is ICUI or AVNS more profitable?

Do analysts rate ICUI or AVNS?

Which has more volatility and risk, ICUI or AVNS?

Does the media refer more to ICUI or AVNS?

Do insiders & institutionals have more ownership in ICUI or AVNS?

Which has preferable earnings & valuation, ICUI or AVNS?

Summary

How does Avanos Medical compare to Envista?

Is NVST or AVNS more profitable?

Do analysts recommend NVST or AVNS?

Do institutionals and insiders have more ownership in NVST or AVNS?

Does the media favor NVST or AVNS?

Which has stronger earnings and valuation, NVST or AVNS?

Which has more risk and volatility, NVST or AVNS?

Summary

How does Avanos Medical compare to Neogen?

Which has stronger earnings & valuation, NEOG or AVNS?

Which has more volatility and risk, NEOG or AVNS?

Do analysts prefer NEOG or AVNS?

Is NEOG or AVNS more profitable?

Does the media refer more to NEOG or AVNS?

Do institutionals & insiders hold more shares of NEOG or AVNS?

Summary

How does Avanos Medical compare to UFP Technologies?

Do institutionals & insiders have more ownership in AVNS or UFPT?

Do analysts prefer AVNS or UFPT?

Which has more risk and volatility, AVNS or UFPT?

Is AVNS or UFPT more profitable?

Does the media prefer AVNS or UFPT?

Which has higher valuation & earnings, AVNS or UFPT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS vs. The Competition

Avanos Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools